Bone Tumor Suppression in Rabbits by Hyperthermia below the Clinical Safety Limit Using Aligned Magnetic Bone Cement
Source abstract
Abstract
Abstract Demonstrating highly efficient alternating current (AC) magnetic field heating of nanoparticles in physiological environments under clinically safe field parameters has remained a great challenge, hindering clinical applications of magnetic hyperthermia. In this work, exceptionally high loss power of magnetic bone cement under the clinical safety limit of AC field parameters, incorporating direct current field‐aligned soft magnetic Zn0.3Fe2.7O4 nanoparticles with low concentration, is reported. Under an AC field of 4 kA m−1 at 430 kHz, the aligned bone cement with 0.2 wt% nanoparticles achieves a temperature increase of 30 °C in 180 s. This amounts to a specific loss power value of 327 W and an intrinsic loss power of 47 nHm2 kg−1, which is enhanced by 50‐fold compared to randomly oriented samples. The high‐performance magnetic bone cement allows for the demonstration of effective hyperthermia suppression of tumor growth in the bone marrow cavity of New Zealand White Rabbits subjected to rapid cooling due to blood circulation, and significant enhancement of survival rate.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physics Capital Normal University Beijing 100048 China
Department of Orthopedics Peking University Third Hospital Beijing 100191 China
Department of Physics University at Buffalo SUNY Buffalo NY 14260 USA
Department of Intensive Care Unit Peking University Third Hospital Beijing 100191 China
Department of Radiation Oncology Columbia University Medical Center New York NY 10032 USA
Funding
National Natural Science Foundation of China · Natural Science Foundation of Beijing Municipality
References (71)
Show source-provided references
1. 10.1097/00000658-195710000-0000710.1097/00000658-195710000-00007 ↗
2. 10.1021/acs.nanolett.5b0476110.1021/acs.nanolett.5b04761 ↗
3. 10.1088/0957-4484/25/45/45200110.1088/0957-4484/25/45/452001 ↗
4. 10.1016/S0304-8853(02)00706-010.1016/S0304-8853(02)00706-0 ↗
5. 10.3109/02656736.2013.83675810.3109/02656736.2013.836758 ↗
6. 10.1038/nnano.2011.9510.1038/nnano.2011.95 ↗
7. 10.1021/nl302160d10.1021/nl302160d ↗
8. 10.1021/mp400015b10.1021/mp400015b ↗
9. 10.1021/nn500454n10.1021/nn500454n ↗
10. 10.1016/S1470-2045(02)00818-510.1016/S1470-2045(02)00818-5 ↗
11. 10.1038/nnano.2010.12510.1038/nnano.2010.125 ↗
12. 10.1126/science.126182110.1126/science.1261821 ↗
13. 10.1021/nn403526610.1021/nn4035266 ↗
14. 10.1002/smll.20180013510.1002/smll.201800135 ↗
15. 10.1109/TMAG.2011.217347410.1109/TMAG.2011.2173474 ↗
16. 10.1021/nn204813710.1021/nn2048137 ↗
17. 10.1088/1361-6463/abdb0e10.1088/1361-6463/abdb0e ↗
18. 10.1021/acs.jpcc.6b0200610.1021/acs.jpcc.6b02006 ↗
19. 10.1021/acs.jpcc.9b0659910.1021/acs.jpcc.9b06599 ↗
20. 10.1021/acsami.8b1622610.1021/acsami.8b16226 ↗
21. 10.1021/acsnano.5b0724910.1021/acsnano.5b07249 ↗
22. 10.1021/acsnano.8b0654210.1021/acsnano.8b06542 ↗
23. 10.1021/acsnano.8b0089310.1021/acsnano.8b00893 ↗
24. 10.1021/acsnano.9b0613410.1021/acsnano.9b06134 ↗
25. 10.3390/nano1011231010.3390/nano10112310 ↗
26. 10.1021/acsami.1c0233810.1021/acsami.1c02338 ↗
27. 10.1021/acsami.0c2134910.1021/acsami.0c21349 ↗
28. 10.3390/pharmaceutics1211102010.3390/pharmaceutics12111020 ↗
29. 10.1021/acsnano.9b0197910.1021/acsnano.9b01979 ↗
30. 10.1109/TMAG.2021.309791510.1109/TMAG.2021.3097915 ↗
31. 10.3390/nano1103061810.3390/nano11030618 ↗
32. 10.1002/adhm.20190010210.1002/adhm.201900102 ↗
33. 10.1016/j.jmmm.2014.09.06910.1016/j.jmmm.2014.09.069 ↗
34. 10.1109/TMAG.2014.232724510.1109/TMAG.2014.2327245 ↗
35. 10.1002/adfm.20190707110.1002/adfm.201907071 ↗
36. 10.1002/jor.110011061110.1002/jor.1100110611 ↗
37. 10.1002/adma.20140250910.1002/adma.201402509 ↗
38. 10.1080/0265673050015836010.1080/02656730500158360 ↗
39. 10.1007/s11060-006-9195-010.1007/s11060-006-9195-0 ↗
40. 10.1080/0265673060110603710.1080/02656730601106037 ↗
41. 10.3390/ma1404070610.3390/ma14040706 ↗
42. 10.1080/0265673080210475710.1080/02656730802104757 ↗
43. 10.1080/02656736.2020.180083110.1080/02656736.2020.1800831 ↗
44. 10.3109/02656736.2013.82299310.3109/02656736.2013.822993 ↗
45. 10.1080/10667857.2019.170680910.1080/10667857.2019.1706809 ↗
46. 10.1021/acsami.0c1276910.1021/acsami.0c12769 ↗
47. 10.1016/j.ceramint.2021.01.08010.1016/j.ceramint.2021.01.080 ↗
48. 10.1021/acsbiomaterials.9b0047210.1021/acsbiomaterials.9b00472 ↗
49. 10.1016/j.jmmm.2018.10.07010.1016/j.jmmm.2018.10.070 ↗
50. 10.1016/j.msec.2019.11046010.1016/j.msec.2019.110460 ↗
51. 10.7150/thno.3415710.7150/thno.34157 ↗
52. 10.1016/j.ssc.2006.01.01410.1016/j.ssc.2006.01.014 ↗
53. 10.2217/nnm.12.9810.2217/nnm.12.98 ↗
54. 10.1155/2015/83676110.1155/2015/836761 ↗
55. 10.1021/acsnano.7b0899510.1021/acsnano.7b08995 ↗
56. 10.1103/PhysRevB.76.21240310.1103/PhysRevB.76.212403 ↗
57. 10.1063/1.312644410.1063/1.3126444 ↗
58. 10.1016/j.jallcom.2016.12.30210.1016/j.jallcom.2016.12.302 ↗
59. 10.1103/PhysRevB.87.17441910.1103/PhysRevB.87.174419 ↗
60. 10.1016/j.jmmm.2019.16617010.1016/j.jmmm.2019.166170 ↗
61. 10.1016/S0304-8853(98)00243-110.1016/S0304-8853(98)00243-1 ↗
62. 10.1103/PhysRevLett.63.45710.1103/PhysRevLett.63.457 ↗
63. 10.1063/1.355158210.1063/1.3551582 ↗
64. 10.1002/pssa.221118013310.1002/pssa.2211180133 ↗
65. 10.1109/TMAG.2013.224952410.1109/TMAG.2013.2249524 ↗
66. 10.1103/PhysRev.96.133510.1103/PhysRev.96.1335 ↗
67. 10.1039/C7NR02356A10.1039/C7NR02356A ↗
68. 10.1021/ja026501x10.1021/ja026501x ↗
69. 10.1021/ja038085210.1021/ja0380852 ↗
70. 10.1016/j.polymertesting.2019.02.01510.1016/j.polymertesting.2019.02.015 ↗
71. 10.1002/adma.20190749110.1002/adma.201907491 ↗